Roeb, E., Canbay, A., Bantel, H., Bojunga, J., de Laffolie, J., Demir, M., . . . Tacke, F. (2024). Amendment “New nomenclature for MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)” to the S2k guideline “Non-alcoholic fatty liver disease” (v.2.0/April 2022) of the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS). Zeitschrift für Gastroenterologie, 62(12), . https://doi.org/10.1055/a-2408-3429
Chicago-Zitierstil (17. Ausg.)Roeb, Elke, et al. "Amendment “New Nomenclature for MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)” to the S2k Guideline “Non-alcoholic Fatty Liver Disease” (v.2.0/April 2022) of the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS)." Zeitschrift Für Gastroenterologie 62, no. 12 (2024). https://doi.org/10.1055/a-2408-3429.
MLA-Zitierstil (9. Ausg.)Roeb, Elke, et al. "Amendment “New Nomenclature for MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)” to the S2k Guideline “Non-alcoholic Fatty Liver Disease” (v.2.0/April 2022) of the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS)." Zeitschrift Für Gastroenterologie, vol. 62, no. 12, 2024, https://doi.org/10.1055/a-2408-3429.